Skip to main content
. 2015 Apr 16;3(4):330–337. doi: 10.12998/wjcc.v3.i4.330

Figure 3.

Figure 3

Coagulation cascade. Factors Xa and IIa (thrombin) are the principal targets for the new oral anticoagulants, while factors II, VII, IX, X, and protein C and S are decreased by the vitamin K antagonist, warfarin. Warfarin’s effect on the factor VIIa/TF complex is a possible cause of the increased intracranial bleeding seen in warfarin compared to the newer targeted agents.